Novartis Ag (NVS) Other Non-Current Assets (2011 - 2026)
Novartis Ag (NVS) recorded Other Non-Current Assets of $5.93 billion in Q2 2026, up 32.5% from $4.47 billion a year earlier and up 19.0% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Other Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Novartis Ag reported Other Non-Current Assets of $5.28 billion, up 50.5% from FY2024.
- Annual Other Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 42.7% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $3.51 billion in FY2024 (+192.3%), $1.2 billion in FY2023 (+8.0%), $1.11 billion in FY2022 (-49.8%) and $2.21 billion in FY2021 (+147.8%).
- The Q2 2026 figure is the highest quarterly Other Non-Current Assets since Q4 2014.
- On a year-over-year basis, Other Non-Current Assets has increased for nine consecutive quarters, with growth averaging 122.1% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 244.3% in Q3 2025, against a decline of 68.9% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.98 billion (Q1 2026), $5.28 billion (Q4 2025) and $4.78 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 14.27 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.93 Bn |
| Mar 31, 2026 | 4.98 Bn |
| Dec 31, 2025 | 5.28 Bn |
| Sep 30, 2025 | 4.78 Bn |
| Jun 30, 2025 | 4.47 Bn |
| Mar 31, 2025 | 4.11 Bn |
| Dec 31, 2024 | 3.51 Bn |
| Sep 30, 2024 | 1.39 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.21 Bn |
| Dec 31, 2023 | 1.20 Bn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.21 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 3.19 Bn |
| Jun 30, 2022 | 3.89 Bn |
| Mar 31, 2022 | 3.86 Bn |
| Dec 31, 2021 | 2.21 Bn |
| Sep 30, 2021 | 2.13 Bn |
API Access
Novartis Ag Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();